Klein, Bianca
179  results:
Search for persons X
?
2

Optimized cytogenetic risk-group stratification of KMT2A-re..:

van Weelderen, Romy E ; Harrison, Christine J ; Klein, Kim...
https://pure.eur.nl/en/publications/50ac940e-30e3-4570-a22c-520de592de85.  , 2024
 
?
4

Optimized cytogenetic risk-group stratification of KMT2A-re..:

van Weelderen, Romy E ; Harrison, Christine J ; Klein, Kim...
https://pure.au.dk/portal/en/publications/41b94d65-8984-40bd-9cd9-cfe51cd9b4a7.  , 2024
 
?
6

Wytyczne ESC 2023 dotyczące leczenia chorób sercowo-naczyni..:

Marx, Nikolaus ; Federici, Massimo ; Schütt, Katharina...
https://journals.viamedica.pl/polish_heart_journal/article/view/99503.  , 2024
 
?
8

Treating CD33-Positive de novo Acute Myeloid Leukemia in Pe..:

Wijnen, Noa E ; Koedijk, Joost B ; Klein, Kim...
https://pure.eur.nl/en/publications/325e0f9a-e02f-484b-a6f1-3c4ee89c02be.  , 2023
 
?
11

Measurable Residual Disease and Fusion Partner Independentl..:

van Weelderen, Romy E ; Klein, Kim ; Harrison, Christine J...
https://research.vumc.nl/en/publications/837bc95f-e282-464a-beb3-9cb01df08e8c.  , 2023
 
?
12

Measurable residual disease and fusion partner independentl..:

van Weelderen, Romy E ; Klein, Kim ; Harrison, Christine J...
Journal of Clinical Oncology, 0732-183X, 2023, 41:16, s. 2963-2974.  , 2023
 
?
13

2023 ESC Guidelines for the management of cardiovascular di..:

Marx, Nikolaus ; Federici, Massimo ; Schütt, Katharina...
https://pure.au.dk/portal/en/publications/e919ed11-d0c0-4ed4-8961-0e77370dd54a.  , 2023
 
1-15